KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today announced that the compensation committee of KalVista’s board of directors granted six n...
What is the projected timeline for potential future grants under Nasdaq Listing Rule 5635(c)(4) for KalVista?
Will the issuance of these options affect the overall option pool size and future ability to grant equity to other employees?
How might the grant influence the overall compensation mix and future hiring incentives at KalVista?
Symbol:
KALV
19 days ago